Streetbeat News

Stock Prices

BNTX

In the past three months, 12 analysts have provided ratings for BioNTech (NASDAQ:BNTX), with a mix of bullish and bearish perspectives. The average 12-month price target is $110.92, slightly down from the previous $111.60. Analysts have maintained, raised, or lowered their ratings and price targets based on recent developments. BioNTech faces financial challenges, including a significant revenue decline and negative net margins, but shows strong return on equity and prudent debt management.

Portfolio Pulse from Benzinga Insights

June 26, 2024 | 12:00 pm

MU

Micron Technology, Inc. (NASDAQ:MU) is set to release its Q3 earnings report, with analysts expecting a significant improvement in earnings per share and revenue. Rosenblatt analyst Hans Mosesmann has maintained a Buy rating with a $225 price target. Micron offers a modest annual dividend yield of 0.33%, translating to a quarterly dividend of 11.5 cents per share. The article also provides calculations for investors aiming to earn $500 or $100 monthly from dividends.

Portfolio Pulse from Avi Kapoor

June 26, 2024 | 12:00 pm

CBUS

Cibus has announced the issuance of additional patents for 10 plant trait and editing families over the past two quarters. This development is significant for the company's growth and innovation in agricultural biotechnology.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 12:00 pm

TSLA

Morgan Stanley analyst Adam Jonas predicts a decline in Tesla's auto revenue but expects significant growth in its energy segment. Tesla Energy is valued at $36 per share of Jonas's $310 price target, with anticipated revenue of $7 billion in 2024, up 20% from 2023. Tesla's energy margins are expected to surpass auto margins this year.

Portfolio Pulse from Anan Ashraf

June 26, 2024 | 11:59 am

ADAUSD

BTCUSD

ETHUSD

Cardano founder Charles Hoskinson expressed confidence that Cardano (ADA) will surpass Bitcoin (BTC) to become the world's largest cryptocurrency. Despite ADA's 35% decline year-to-date, Hoskinson remains optimistic about its future, criticizing Bitcoin's maximalism and U.S. cryptocurrency policies.

Portfolio Pulse from Aniket Verma

June 26, 2024 | 11:58 am

BALL

NUE

OI

The article highlights three oversold stocks in the materials sector that may present buying opportunities in Q2: Ball Corp (NYSE:BALL), O-I Glass Inc (NYSE:OI), and Nucor Corp (NYSE:NUE). These stocks have RSI values near or below 30, indicating potential undervaluation.

Portfolio Pulse from Avi Kapoor

June 26, 2024 | 11:56 am

ANEW

ANEW Medical shares are trading higher after the company announced it has been granted a European patent for its Klotho gene sequence and gene delivery systems for treating neurodegenerative diseases.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 11:55 am

AAPL

NVDA

QCOM

TSM

Analysts predict Taiwan's semiconductor industry, led by Taiwan Semiconductor Manufacturing Co (TSMC), will maintain its global lead for the next 8-10 years. TSMC, a key supplier to Nvidia and Apple, faces geopolitical pressures but is expected to continue dominating the market. TSMC stock has gained over 72% in the last 12 months.

Portfolio Pulse from Anusuya Lahiri

June 26, 2024 | 11:50 am

ANNX

Annexon shares are trading higher after the company announced positive results from the Phase 3 trial of its C1q-targeted immunotherapy, ANX005, in Guillain-Barré Syndrome at the 2024 Peripheral Nerve Society Annual Meeting.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 11:47 am

TSHA

Taysha Gene Therapies shares are trading lower following the announcement of a $75 million underwritten public offering of common stock and pre-funded warrants.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 11:45 am